Increased NKG2A expression by NK1.1+ cells in a T1D mouse model can enhance allograft survival, increase insulin secretion, and reduce the inflammatory response to allografts in an IL-22-dependent manner. This evidence concerns the gene INS and type 1 diabetes mellitus.